Separation of antileukemic effects from graft-versus-host disease in MHC-haploidentical murine bone marrow transplantation: Participation of host immune cells

International Journal of Hematology

Volumn 91, Issue 3, 2010, Pages 485-497

  Satake, Atsushi ^a   Inoue, Takayuki ^a   Kubo, Shuji ^a   Taniguchi, Yuki ^a   Imado, Takehito ^a   Fujioka, Tatsuya ^a   Horiuchi, Marika ^a   Xu, Yunfeng ^a   Ikegame, Kazuhiro ^a   Yoshihara, Satoshi ^a   Kaida, Katsuji ^a   Tamaki, Hiroya ^a   Okada, Masaya ^a   Okamura, Haruki ^a   Ogawa, Hiroyasu ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

GVHD; GVL; Interferon ; MHC mismatched hematopoietic stem cell transplantation; Natural killer cell

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; INTERFERON PRODUCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MIXED LYMPHOCYTE CULTURE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; SPLEEN CELL; T CELL DEPLETION; WHOLE BODY RADIATION;

ANIMALS; BONE MARROW TRANSPLANTATION; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; HAPLOTYPES; HISTOCOMPATIBILITY; INTERFERON-GAMMA; INTESTINE, LARGE; KILLER CELLS, NATURAL; LIVER; LYMPHOCYTE CULTURE TEST, MIXED; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED DBA; RECEPTORS, CXCR3; SPLEEN;

EID: 77950902514     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-010-0545-5     Document Type: Article

References (38)

1. ED Thomas 1983 Karnofsky memorial lecture. Marrow transplantation for malignant diseases J Clin Oncol 1 517 531 1:STN:280:DyaL2c7jslynsw%3D%3D 6366143
2. MM Bortin AA Rimm 1986 Increasing utilization of bone marrow transplantation Transplantation 42 229 234 10.1097/00007890-198609000-00001 1:STN:280:DyaL28zhs12lug%3D%3D 3529523 (Pubitemid 16020742)
3. RP Gale 1985 Graft-versus-host disease Immunol Rev 88 193 214 10.1111/j.1600-065X.1985.tb01159.x 1:STN:280:DyaL287htVaksQ%3D%3D 3910557
4. O Ringden B Nilsson 1985 Death by graft-versus-host disease associated with HLA mismatch, high recipient age, low marrow cell dose, and splenectomy Transplantation 40 39 44 1:STN:280:DyaL2M3ksFOnsw%3D%3D 3892795 (Pubitemid 15013436)
5. K Ikegame Y Tanji N Kitai H Tamaki M Kawakami T Fujioka, et al. 2003 Successful treatment of refractory T-cell acute lymphoblastic leukemia by unmanipulated stem cell transplantation from an HLA 3-loci mismatched (haploidentical) sibling Bone Marrow Transplant 31 507 510 10.1038/sj.bmt. 1703858 1:STN:280:DC%2BD3s7kvFCqtQ%3D%3D 12665848 (Pubitemid 36511819)
6. H Ogawa K Ikegame M Kawakami A Tsuboi EH Kim N Hosen, et al. 2004 Powerful graft-versus-leukemia effects exerted by HLA-haploidentical grafts engrafted with a reduced-intensity regimen for relapse following myeloablative HLA-matched transplantation Transplantation 78 488 489 10.1097/01.TP.0000128627. 28212.D7 15316386 (Pubitemid 39095423)
7. H Ogawa K Ikegame S Yoshihara M Kawakami T Fujioka T Masuda, et al. 2006 Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning Biol Blood Marrow Transplant 12 1073 1084 10.1016/j.bbmt.2006.06.007 17084371
8. H Ogawa K Ikegame K Kaida S Yoshihara T Fujioka Y Taniguchi, et al. 2008 Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis Exp Hematol 36 1 8 10.1016/j.exphem.2007.08.013 1:CAS:528:DC%2BD2sXhsVOrsbfJ 17920757 (Pubitemid 350266965)
9. M Murai H Yoneyama T Ezaki M Suematsu Y Terashima A Harada, et al. 2003 Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction Nat Immunol 4 154 160 10.1038/ni879 1:CAS:528:DC%2BD3sXmslKjtw%3D%3D 12524535 (Pubitemid 36193017)
10. LA Welniak BR Blazar MR Anver RH Wiltrout WJ Murphy 2000 Opposing roles of interferon-gamma on CD4+ T cell-mediated graft-versus-host disease: effects of conditioning Biol Blood Marrow Transplant 6 604 612 10.1016/S1083-8791(00) 70025-5 1:CAS:528:DC%2BD3cXovVGhtbs%3D 11128810
11. YG Yang J Qi MG Wang M Sykes 2002 Donor-derived interferon gamma separates graft-versus-leukemia effects and graft-versus-host disease induced by donor CD8 T cells Blood 99 4207 4215 10.1182/blood.V99.11.4207 1:CAS:528:DC%2BD38XktFyrtrg%3D 12010827 (Pubitemid 35332067)
12. H Wang W Asavaroengchai BY Yeap MG Wang S Wang M Sykes, et al. 2009 Paradoxical effects of IFN-gamma in graft-versus-host disease reflect promotion of lymphohematopoietic graft-versus-host reactions and inhibition of epithelial tissue injury Blood 113 3612 3619 10.1182/blood-2008-07-168419 1:CAS:528:DC%2BD1MXkslCrsrY%3D 19211507
13. HP Brok PJ Heidt PH van der Meide C Zurcher JM Vossen 1993 Interferon-gamma prevents graft-versus-host disease after allogeneic bone marrow transplantation in mice J Immunol 151 6451 6459 1:CAS:528:DyaK2cXnsFWnsQ%3D%3D 8245478 (Pubitemid 2023407)
14. AC Burman T Banovic RD Kuns AD Clouston AC Stanley ES Morris, et al. 2007 IFNγ differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract Blood 110 1064 1072 10.1182/blood-2006-12-063982 1:CAS:528:DC%2BD2sXos1Cqt74%3D 17449800 (Pubitemid 47267449)
15. KR Cooke L Kobzik TR Martin J Brewer J Delmonte Jr JM Crawford, et al. 1996 An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation. I. The roles of minor H antigens and endotoxin Blood 88 3230 3239 1:CAS:528:DyaK28XmtlWju7w%3D 8963063 (Pubitemid 26357409)
16. Y Yoshida T Hirano G Son Y Iimuro T Imado T Iwasaki, et al. 2007 Allogeneic bone marrow transplantation for hepatocellular carcinoma: hepatocyte growth factor suppresses graft-vs.-host disease Am J Physiol Gastrointest Liver Physiol 293 G1114 G1123 10.1152/ajpgi.00026.2007 1:CAS:528:DC%2BD2sXhsVGls7bP 17761834 (Pubitemid 350255053)
17. S Kubo MC Seleme HS Soifer JL Perez JV Moran HH Kazazian Jr, et al. 2006 L1 retrotransposition in nondividing and primary human somatic cells Proc Natl Acad Sci USA 103 8036 8041 10.1073/pnas.0601954103 1:CAS:528: DC%2BD28Xlt1Chtr8%3D 16698926 (Pubitemid 43801048)
18. N Nakagomi T Nakagomi S Kubo A Nakano-Doi O Saino M Takata, et al. 2009 Endothelial cells support survival, proliferation and neuronal differentiation of transplanted adult ischemia-induced neural stem/progenitor cells after cerebral infarction Stem Cells 27 2185 2195 10.1002/stem.161 19557831
19. T Barrett Y Koyama Y Hama G Ravizzini IS Shin BS Jang, et al. 2007 In vivo diagnosis of epidermal growth factor receptor expression using molecular imaging with a cocktail of optically labeled monoclonal antibodies Clin Cancer Res 13 6639 6648 10.1158/1078-0432.CCR-07-1119 1:CAS:528:DC%2BD2sXhtlSmu7nK 17982120 (Pubitemid 350206799)
20. T Iwasaki H Fujiwara GM Shearer 1986 Loss of proliferative capacity and T cell immune development potential by bone marrow from mice undergoing a graft-vs-host reaction J Immunol 137 3100 3108 1:STN:280:DyaL2s%2FjsV2huw%3D%3D 2945856 (Pubitemid 17181674)
21. M Jaksch M Remberger J Mattsson 2005 Increased gene expression of chemokine receptors is correlated with acute graft-versus-host disease after allogeneic stem cell transplantation Biol Blood Marrow Transplant 11 280 287 10.1016/j.bbmt.2005.01.004 1:CAS:528:DC%2BD2MXktVOqtro%3D 15812393 (Pubitemid 40450755)
22. R Sackstein 2006 A revision of Billingham's tenets: the central role of lymphocyte migration in acute graft-versus-host disease Biol Blood Marrow Transplant 12 2 8 10.1016/j.bbmt.2005.09.015 16399577 (Pubitemid 43034112)
23. GR Hill JL Ferrara 2000 The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation Blood 95 2754 2759 1:CAS:528:DC%2BD3cXivVarurw%3D 10779417
24. A Snijders P Kalinski CM Hilkens ML Kapsenberg 1998 High-level IL-12 production by human dendritic cells requires two signals Int Immunol 10 1593 1598 10.1093/intimm/10.11.1593 1:CAS:528:DyaK1cXns1Ghsro%3D 9846688 (Pubitemid 28502373)
25. M Afkarian JR Sedy J Yang NG Jacobson N Cereb SY Yang, et al. 2002 T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cells Nat Immunol 3 549 557 10.1038/ni794 1:CAS:528:DC%2BD38XjvFOmsbo%3D 12006974 (Pubitemid 34662307)
26. A Martín-Fontecha LL Thomsen S Brett C Gerard M Lipp A Lanzavecchia, et al. 2004 Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming Nat Immunol 5 1260 1265 10.1038/ni1138 15531883 (Pubitemid 41057741)
27. A Moretta 2002 Natural killer cells and dendritic cells: rendezvous in abused tissues Nat Rev Immunol 2 957 964 10.1038/nri956 1:CAS:528: DC%2BD38XptFKnu7Y%3D 12461568 (Pubitemid 37323216)
28. MR Pelot DA Pearson K Swenson G Zhao J Sachs YG Yang, et al. 1999 Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen Biol Blood Marrow Transplant 5 133 143 10.1053/bbmt.1999.v5.pm10392959 1:STN:280: DyaK1MzitVWgsg%3D%3D 10392959
29. M Rottman C Soudais G Vogt L Renia JF Emile H Decaluwe, et al. 2008 IFN-gamma mediates the rejection of haematopoietic stem cells in IFN-gammaR1-deficient hosts PLoS Med 5 e26 10.1371/journal.pmed.0050026 18232731 (Pubitemid 351198269)
30. W Böhm S Thoma F Leithäuser P Möller R Schirmbeck J Reimann 1998 T cell-mediated, IFN-gamma-facilitated rejection of murine B16 melanomas J Immunol 161 897 908 9670968 (Pubitemid 28323555)
31. TJ Sayers AD Brooks JK Lee RG Fenton KL Komschlies JM Wigginton, et al. 1998 Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells J Immunol 161 3957 3965 1:CAS:528:DyaK1cXmsFyrt7k%3D 9780164
32. R Puliaev P Nguyen FD Finkelman CS Via 2004 Differential requirement for IFN-gamma in CTL maturation in acute murine graft-versus-host disease J Immunol 173 910 919 1:CAS:528:DC%2BD2cXlsVGhurw%3D 15240678 (Pubitemid 38924264)
33. TJ Sayers TA Wiltrout K McCormick C Husted RH Wiltrout 1990 Antitumor effects of alpha-interferon and gamma-interferon on a murine renal cancer (Renca) in vitro and in vivo Cancer Res 50 5414 5420 1:CAS:528: DyaK3cXlsFSms7o%3D 2117482 (Pubitemid 20302997)
34. VP Badovinac AR Tvinnereim JT Harty 2000 Regulation of antigen-specific CD8+ T cell homeostasis by perforin and interferon-gamma Science 17 1354 1358 10.1126/science.290.5495.1354
35. LE Harrington RD Hatton PR Mangan H Turner TL Murphy KM Murphy, et al. 2005 Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages Nat Immunol 6 1123 1132 10.1038/ni1254 1:CAS:528:DC%2BD2MXhtFamsb7J 16200070 (Pubitemid 41541790)
36. B Sawitzki CI Kingsley V Oliveira M Karim M Herber KJ Wood 2005 IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo J Exp Med 201 1925 1935 10.1084/jem.20050419 1:CAS:528:DC%2BD2MXls1Witbk%3D 15967822 (Pubitemid 41002929)
37. D Polchert J Sobinsky GW Douglas M Kidd A Moadsiri E Reina, et al. 2008 IFN-γ activation of mesenchymal stem cells for treatment and prevention of graft versus host disease Eur J Immunol 38 1745 1755 10.1002/eji.200738129 1:CAS:528:DC%2BD1cXnsF2gsro%3D 18493986
38. K English FP Barry CP Field-Corbett BP Mahon 2007 IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells Immunol Lett 110 91 100 10.1016/j.imlet.2007.04.001 1:CAS:528: DC%2BD2sXmtVantb4%3D 17507101 (Pubitemid 46830943)